What is Ever/Body?
Ever/Body operates as a skincare service spa, offering a range of treatments and products designed to enhance skin health and appearance. Based in New York, the company aims to provide a comprehensive skincare experience, blending professional services with curated product offerings. The company's growth trajectory, marked by multiple funding rounds, indicates a strong market reception and a strategic expansion plan.
How much funding has Ever/Body raised?
Ever/Body has raised a total of $110.9M across 4 funding rounds:
Series A
$17M
Debt
$401K
Series B
$38M
Series C
$55.5M
Series A (2019): $17M with participation from Redesign Health, Declaration Partners, ACME Capital, and Tiger Global Management
Debt (2021): $401K led by PPP
Series B (2021): $38M supported by Tiger Global Management, Addition, Redesign Health, Gaingels, Acme Capital, Declaration Partners, Fifth Wall, and MetaProp
Series C (2022): $55.5M featuring Acme Capital, Declare Capital, and Tiger Global Management
Key Investors in Ever/Body
Tiger Global Management
Tiger Global Management is an investment firm deploying capital in both public and private markets. The company was founded in 2001 and is headquartered in New York City, New York.
Redesign Health
Founded in 2018. Redesign Health is powering a new kind of innovation in healthcare. We ideate, build, and scale solutions to solve the biggest health challenges and rapidly advance human health.
Gaingels
Gaingels is the leading investment syndicate in support of and representing the LGBTQ community and allies in the venture capital space. With over $380,000,000 deployed into a portfolio of over 600 companies since 2014, Gaingels is also the co-founder of Mathison.io and provides an internal at-cost diverse board member/observer recruitment advisory for the company's portfolio companies. Gaingels invests in companies with LGBT founders and C-suite leaders at all stages of growth, as well as in other high-growth companies resolved on building more inclusive teams. Gaingels is a founding co-signer of the Diversity Term Sheet Rider Initiative to increase access to venture funding events for non-traditional check writers, and regularly co-invests with select VC leads across a variety of sectors, from technology, to B2B, healthcare and consumer, in competitive and over-subscribed rounds from Seed to Growth/pre-IPO.
What's next for Ever/Body?
The recent major strategic investment in Ever/Body signals a pivotal phase for the company, likely focused on scaling operations, expanding its service footprint, and potentially enhancing its product lines. This infusion of capital will enable Ever/Body to further solidify its market presence and innovate within the skincare industry, leveraging its established service model and brand reputation. Future developments may include broader market penetration and the introduction of new service offerings or technologies to meet evolving consumer demands.
See full Ever/Body company page
